Two types of nanoparticle-based bio-barcode amplification assays to detect HIV-1 p24 antigen

Virology Journal

Volumn 9, Issue , 2012, Pages

  Dong, Huahuang ^a   Liu, Jianli ^b   Zhu, Hong ^b   Ou, Chin Yih ^c   Xing, Wenge ^a   Qiu, Maofeng ^a   Zhang, Guiyun ^a   Xiao, Yao ^a   Yao, Jun ^a   Pan, Pinliang ^a   Jiang, Yan ^a  

^a National Center for AIDS   (China)

^b Beijing Exit and Entry Inspection and Quarantine Bureau   (China)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Bio barcode amplification; Human immunodeficiency viruses; p24 detection

Indexed keywords

AGAROSE; ANTIGEN P24; DOUBLE STRANDED DNA; GOLD NANOPARTICLE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE;

ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA PROBE; DNA STRAND; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LIMIT OF DETECTION; NANOPARTICLE BASED BIO BARCODE AMPLIFICATION MAGNETIC MICROPARTICLE ASSAY; NANOPARTICLE BASED BIO BARCODE AMPLIFICATION MICROPLATE WELL ASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, MONOCLONAL; ELECTROPHORESIS, AGAR GEL; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NANOPARTICLES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84865531863     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-180     Document Type: Article

References (30)

1. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP, AIDS 2003 17 1871 1879 10.1097/00002030- 200309050-00005 12960819 (Pubitemid 37070272)
2. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions. Prado JG, Shintani A, Bofill M, Clotet B, Ruiz L, Martinez-Picado J, J Clin Microbiol 2004 42 1620 1625 10.1128/JCM.42.4.1620-1625.2004 15071015 (Pubitemid 38500806)
3. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, Danel C, Anglaret X, Leroy V, Msellati P, et al. J Clin Microbiol 2005 43 2709 2717 10.1128/JCM.43.6.2709- 2717.2005 15956387 (Pubitemid 40827943)
4. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. Jennings C, Fiscus SA, Crowe SM, Danilovic AD, Morack RJ, Scianna S, Cachafeiro A, Brambilla DJ, Schupbach J, Stevens W, et al. J Clin Microbiol 2005 43 5950 5956 10.1128/JCM.43.12.5950-5956.2005 16333081 (Pubitemid 43100643)
5. Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings. Sivapalasingam S, Essajee S, Nyambi PN, Itri V, Hanna B, Holzman R, Valentine F, J Clin Microbiol 2005 43 3793 3796 10.1128/JCM.43.8.3793-3796.2005 16081912 (Pubitemid 41129662)
6. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. Respess RA, Cachafeiro A, Withum D, Fiscus SA, Newman D, Branson B, Varnier OE, Lewis K, Dondero TJ, J Clin Microbiol 2005 43 506 508 10.1128/JCM.43.1.506-508.2005 15635029 (Pubitemid 40096358)
7. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. Ribas SG, Ondoa P, Schupbach J, van der Groen G, Fransen K, J Virol Methods 2003 113 29 34 10.1016/S0166-0934(03)00219-2 14500124 (Pubitemid 37297700)
8. HIV diagnostic testing: evolving technology and testing strategies. Daskalakis D, Top Antivir Med 2011 19 18 22 21852712
9. Evidence behind the WHO guidelines: hospital care for children: what is the role of HIV antigen testing in infants <12-months old? Finnegan J, Noble KA, Lodha R, J Trop Pediatr 2009 55 216 218 10.1093/tropej/fmp056 19602485
10. Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti. George E, Beauharnais CA, Brignoli E, Noel F, Bois G, De Matteis RP, Altenor M, Lauture D, Hosty M, Mehta S, et al. J Clin Microbiol 2007 45 3416 3418 10.1128/JCM.01314-07 17670933 (Pubitemid 47585675)
11. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Allain JP, Laurian Y, Paul DA, Senn D, Lancet 1986 2 1233 1236 2878129 (Pubitemid 17182836)
12. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. Schupbach J, Flepp M, Pontelli D, Tomasik Z, Luthy R, Boni J, AIDS 1996 10 1085 1090 8874624 (Pubitemid 26283345)
13. p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. Sutthent R, Gaudart N, Chokpaibulkit K, Tanliang N, Kanoksinsombath C, Chaisilwatana P, J Clin Microbiol 2003 41 1016 1022 10.1128/JCM.41.3.1016-1022.2003 12624024 (Pubitemid 36307101)
14. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. Barletta JM, Edelman DC, Constantine NT, Am J Clin Pathol 2004 122 20 27 10.1309/529T2WDNEB6X8VUN 15272526 (Pubitemid 38849868)
15. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Nam JM, Thaxton CS, Mirkin CA, Science 2003 301 1884 1886 10.1126/science.1088755 14512622 (Pubitemid 37221389)
16. Detection of protein analytes via nanoparticle-based bio bar code technology. Bao YP, Wei TF, Lefebvre PA, An H, He L, Kunkel GT, Muller UR, Anal Chem 2006 78 2055 2059 10.1021/ac051798d 16536446
17. Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. Tang S, Hewlett I, J Infect Dis 2010 201 Suppl 1 59 S64 20225948
18. Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Thaxton CS, Elghanian R, Thomas AD, Stoeva SI, Lee JS, Smith ND, Schaeffer AJ, Klocker H, Horninger W, Bartsch G, Mirkin CA, Proc Natl Acad Sci U S A 2009 106 18437 18442 10.1073/pnas.0904719106 19841273
19. Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. Tang S, Zhao J, Storhoff JJ, Norris PJ, Little RF, Yarchoan R, Stramer SL, Patno T, Domanus M, Dhar A, et al. J Acquir Immune Defic Syndr 2007 46 231 237 10.1097/QAI.0b013e31814a554b 17693896 (Pubitemid 47482620)
20. A fluorophore-based bio-barcode amplification assay for proteins. Oh BK, Nam JM, Lee SW, Mirkin CA, Small 2006 2 103 108 10.1002/smll.200500260 17193564 (Pubitemid 43198003)
21. Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method. Kim EY, Stanton J, Korber BT, Krebs K, Bogdan D, Kunstman K, Wu S, Phair JP, Mirkin CA, Wolinsky SM, Nanomedicine (Lond) 2008 3 293 303 10.2217/17435889.3.3.293 (Pubitemid 351827307)
22. Gold nanoparticle enhanced immuno-PCR for ultrasensitive detection of Hantaan virus nucleocapsid protein. Chen L, Wei H, Guo Y, Cui Z, Zhang Z, Zhang XE, J Immunol Methods 2009 346 64 70 10.1016/j.jim.2009.05.007 19467237
23. Colorimetric bio-barcode amplification assay for cytokines. Nam JM, Wise AR, Groves JT, Anal Chem 2005 77 6985 6988 10.1021/ac0513764 16255599 (Pubitemid 41547295)
24. A bio-bar-code assay based upon dithiothreitol-induced oligonucleotide release. Thaxton CS, Hill HD, Georganopoulou DG, Stoeva SI, Mirkin CA, Anal Chem 2005 77 8174 8178 10.1021/ac0514265 16351173 (Pubitemid 41832008)
25. Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes. Stoeva SI, Lee JS, Smith JE, Rosen ST, Mirkin CA, J Am Chem Soc 2006 128 8378 8379 10.1021/ja0613106 16802785
26. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA, Proc Natl Acad Sci U S A 2005 102 2273 2276 10.1073/pnas.0409336102 15695586 (Pubitemid 40279365)
27. Minimizing DNA contamination by using UNG-coupled quantitative real-time PCR on degraded DNA samples: application to ancient DNA studies. Pruvost M, Grange T, Geigl EM, Biotechniques 2005 38 569 575 10.2144/05384ST03 15884675 (Pubitemid 40529432)
28. Establishment of one-step SYBR green-based real time-PCR assay for rapid detection and quantification of chikungunya virus infection. Ho PS, Ng MM, Chu JJ, Virol J 2010 7 13 10.1186/1743-422X-7-13 20092632
29. Loss of Dact1 disrupts planar cell polarity signaling by altering dishevelled activity and leads to posterior malformation in mice. Wen J, Chiang YJ, Gao C, Xue H, Xu J, Ning Y, Hodes RJ, Gao X, Chen YG, J Biol Chem 2010 285 11023 11030 10.1074/jbc.M109.085381 20145239
30. The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure. Feugate JE, Li Q, Wong L, Martins-Green M, J Cell Biol 2002 156 161 172 10.1083/jcb.200103062 11781340 (Pubitemid 34846944)